Tag: Non-small-cell lung cancer

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Non-small-cell lung cancer

Addition of Savolitinib Can Reverse Osimertinib Resistance in Advanced NSCLC

Added to Collection on: 2025-04-08 19:28:37

Tags for this article:

Lung cancer
Orphan drugs
Acrylamides
Ethers
Osimertinib
Pyrimidines
Non-small-cell lung cancer
Epidermal growth factor receptor
T790M
Myung-Ju Ahn

Click the tags to see associated articles and topics

View Article Details
Gilead's Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer

Added to Collection on: 2025-04-22 12:52:10

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Ivonescimab
Triple-negative breast cancer
Antibody-drug conjugate
Sacituzumab govitecan
Vascular endothelial growth factor
Pembrolizumab
Non-small-cell lung cancer
Programmed cell death protein 1
Bispecific monoclonal antibody
Merck
Gilead

Click the tags to see associated articles and topics

View Article Details
FDA Approves Akeso's PD-1 Monoclonal Antibody for Recurrent or Metastatic Non ...

Added to Collection on: 2025-04-25 16:13:08

Tags for this article:

Lung cancer
Infectious causes of cancer
Orphan drugs
Angiogenesis inhibitors
Antineoplastic drugs
Nasopharyngeal carcinoma
Non-small-cell lung cancer
Ivonescimab
Head and neck cancer
Small-cell carcinoma
Nivolumab
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche's TROP2 ...

Added to Collection on: 2025-05-04 10:04:42

Tags for this article:

Antibody-drug conjugates
Datopotamab deruxtecan
Deruxtecan
Non-small-cell lung cancer
Stephen V Liu
Raffaele Colombo
Zymeworks
AstraZeneca
Roche Diagnostics

Click the tags to see associated articles and topics

View Article Details
PD-1 NSCLC Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by ...

Added to Collection on: 2025-05-06 00:52:00

Tags for this article:

Cancer immunotherapy
Lung cancer
Immune system
Orphan drugs
Antineoplastic drugs
PD-1 and PD-L1 inhibitors
Checkpoint inhibitor
Atezolizumab
Ivonescimab
Non-small-cell lung cancer
Targeted therapy
Programmed cell death protein 1
Non-Small Cell Lung Cancer Companies

Click the tags to see associated articles and topics

View Article Details
Targeted Therapeutics Market To Hit USD 152.9 Bn By 2033

Added to Collection on: 2025-05-06 06:29:21

Tags for this article:

Oncogenes
Biotechnology
Cancer
Biomarkers
Chemical pathology
Targeted therapy
Personalized medicine
Oncology
Breast cancer
HER2
KRAS
Non-small-cell lung cancer

Click the tags to see associated articles and topics

View Article Details
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only ...

Added to Collection on: 2025-05-16 09:08:49

Tags for this article:

Orphan drugs
Lung cancer
Infectious causes of cancer
Antineoplastic drugs
Anal cancer
Gastrointestinal cancer
Non-small-cell lung cancer
Small-cell carcinoma
Pembrolizumab
Treatment of lung cancer
Incyte Corporation
United States
Wilmington
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
FDA Approves Emrelis for High c-Met Protein Overexpressing NSCLC

Added to Collection on: 2025-05-16 14:31:38

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Antibody-drug conjugates
Cancer immunotherapy
Non-small-cell lung cancer
Atezolizumab
Pembrolizumab
vedotin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion ...

Added to Collection on: 2025-05-18 09:00:44

Tags for this article:

Lung cancer
Non-small-cell lung cancer
CEACAM5
Atezolizumab
Roche Diagnostics

Click the tags to see associated articles and topics

View Article Details
Daiichi Sankyo and Merck Pull Back Patritumab Deruxtecan BLA Based on Phase III ...

Added to Collection on: 2025-05-29 21:21:41

Tags for this article:

Antibody-drug conjugates
Amines
Patritumab deruxtecan
Antineoplastic drugs
Lung cancer
Deruxtecan
Antibody-drug conjugate
Daiichi Sankyo
Non-small-cell lung cancer
Epidermal growth factor receptor
Gefitinib
patritumab
HERTHENA

Click the tags to see associated articles and topics

View Article Details
Book a Demo